FDA approves Votrient for advanced soft tissue sarcoma
On April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously…
Oncology
Putting evidence into practice: Pain
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Polypectomy lowers colorectal cancer mortality
A study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who had adenomatous…
Putting evidence into practice: Chemotherapy-induced peripheral neuropathy
This year continues our series from the Oncology Nursing Society on managing cancer-related symptoms.
Are you ready to care for patients in clinical trials?
Part 1 of a four-part series on clinical trials
Putting evidence into practice: Prevention of infection in patients receiving cancer treatments
Learn how you can help reduce the risk of infections in patients receiving treatment for cancer
Cancer survival remains higher in married compared to unmarried
A study, published by BMC Public Health, that examined data from 1970-2007 has found that the excess mortality of never-married compared to married people…
Evidence-based practice in healthcare: Is it on shaky ground?
“Federal panel recommends against prostate cancer screening.” This news headline may have given some nurses a sense of déjà vu, and not for the…
Evidence-based interventions for chemotherapy-induced nausea and vomiting
Learn what you can do to manage this devastating effect of cancer treatment.
FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and…
Chest tube care: The more you know, the easier it gets
Many nurses find chest tube care intimidating—but it doesn’t have to be. Once you understand the basics, you can be confident when caring for…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express the abnormal…
FDA approves Votrient for advanced soft tissue sarcoma
On April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who…
Putting evidence into practice: Pain
The latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Polypectomy lowers colorectal cancer mortality
A study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who…
Putting evidence into practice: Chemotherapy-induced peripheral neuropathy
This year continues our series from the Oncology Nursing Society on managing cancer-related symptoms.
Are you ready to care for patients in clinical trials?
Part 1 of a four-part series on clinical trials
Putting evidence into practice: Prevention of infection in patients receiving cancer treatments
Learn how you can help reduce the risk of infections in patients receiving treatment for cancer
Cancer survival remains higher in married compared to unmarried
A study, published by BMC Public Health, that examined data from 1970-2007 has found that the excess mortality of never-married compared to…
Evidence-based practice in healthcare: Is it on shaky ground?
“Federal panel recommends against prostate cancer screening.” This news headline may have given some nurses a sense of déjà vu, and not…
Evidence-based interventions for chemotherapy-induced nausea and vomiting
Learn what you can do to manage this devastating effect of cancer treatment.
FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from…
Chest tube care: The more you know, the easier it gets
Many nurses find chest tube care intimidating—but it doesn’t have to be. Once you understand the basics, you can be confident when…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express…